Post-cycle therapy (PCT) is the most common protocol in AAS use, yet it is also the most poorly monitored. Most athletes finish PCT, wait a few weeks, check total testosterone, and call it recovered when the number comes back "within range." But a testosterone value of 350 ng/dL does not tell you whether your pituitary is signaling properly, whether your Leydig cells are functional, or whether your fertility has returned.
Your pre-cycle baseline is the single most important reference point for interpreting post-PCT blood work. Without it, you are guessing against a population range that may not reflect your personal set point. If you never measured baseline, use your best historical values or estimate from age and training history. A 30-year-old who cycled for 2 years with 500 mg testosterone weekly will have a different recovery trajectory than a 45-year-old on a 12-week cycle. The HPTA axis is not a switch; it is a feedback loop. LH from the pituitary drives testicular testosterone production, and testosterone feeds back to suppress GnRH. When you stop exogenous testosterone, that loop must re-establish. LH is the first signal to return, often appearing within 2 to 4 weeks. FSH follows a similar timeline but is more sensitive to Sertoli cell activity. Total testosterone lags behind because Leydig cells need sustained LH stimulation to resume production. This is why a single total T reading at week 4 is meaningless without LH and FSH context.
A PCT that merely "worked" and one that delivered genuine recovery are two different outcomes, and the difference shows up in three markers you have to read together: LH, FSH, and total testosterone. Each stage of recovery tells you something specific about how your axis is rebooting, and if the numbers are not where they should be, you need a clear plan for what to do next.
The HPTA Recovery Timeline
HPTA recovery follows a predictable sequence. Understanding this timeline helps you interpret your blood work in context. Expecting full recovery at week 4 is unrealistic, and interpreting partial recovery as failure leads to premature intervention.
Week 4 Post-PCT
LH recovery begins: LH should be rising above 2.0 mIU/mL. FSH typically recovers slightly ahead of LH. If LH is still below 1.5 at week 4, recovery is delayed and continued monitoring is needed. Total testosterone may still be low (200-400 ng/dL range): this is expected at this stage.
A common mistake is expecting LH to jump above 4.0 by week 4. In practice, LH often rises slowly, especially after long cycles or with suppressive compounds like nandrolone. At week 4, an LH of 2.5 with a total T of 300 is actually a positive sign: the pituitary is waking up. The real red flag is LH below 1.0 at week 4, which suggests profound suppression or a slow recovery. If you see LH between 1.5 and 3.0, do not intervene. Retest at week 8. If LH is still below 1.5 at week 8, that is when you consider a second PCT round. Also note that FSH often recovers ahead of LH, so a normal FSH with low LH is not unusual. The key is the trend: LH should be climbing each draw. A single static value tells you little. Track the slope, not the point.
Week 8 Post-PCT
First reliable full assessment: LH should be above 4.0 mIU/mL. FSH above 4.0 mIU/mL. Total testosterone above 350 ng/dL (ideally above 500). This is the earliest point at which you can meaningfully assess recovery. If all three markers meet these thresholds, recovery is on track: but still not confirmed.
FSH above 4.0 mIU/mL is a strong indicator that spermatogenesis is resuming, but it is not a guarantee of fertility. FSH stimulates Sertoli cells, which support sperm production. However, sperm count and quality depend on intratesticular testosterone, which is 100-fold higher than serum levels. That local testosterone is driven by LH, so both hormones must be adequate. If FSH is normal but LH is low, sperm production may still be impaired. Inhibin B, produced by Sertoli cells, is a more direct marker of spermatogenic activity. A normal inhibin B (above 100 pg/mL) with FSH in range suggests active sperm production. But the gold standard remains semen analysis. If fertility is a goal, do not rely on blood work alone. At week 12, if LH and FSH are normal, schedule a semen analysis. If sperm count is low, wait another 3 months and repeat. Spermatogenesis takes 74 days, so improvements appear slowly.
Week 12 Post-PCT
Confirmation: LH > 4.0, FSH > 4.0, total testosterone at or near pre-cycle baseline. If your pre-cycle total T was 650 ng/dL and you are at 550 at week 12, recovery is essentially complete. Values within 80% of baseline are considered full recovery for practical purposes.
Week 16–24 Post-PCT
Spermatogenesis recovery: Semen analysis is the gold standard for fertility recovery. Blood markers (FSH, inhibin B) are useful proxies, but semen analysis provides definitive information. FSH above 4.0 is a good sign that spermatogenesis is active, but sperm count, motility, and morphology require direct measurement.
Estradiol is often overlooked in PCT recovery, but it plays a critical role. During AAS use, aromatase converts testosterone to estradiol, and many users take an AI to control it. After PCT, estradiol can be low, which impairs libido and bone health, but more importantly, low estradiol can blunt LH response. Estradiol is a negative feedback signal to the pituitary, but it also sensitizes Leydig cells to LH. A common pattern is total T in range but estradiol below 20 pg/mL, leaving you feeling flat. If your estradiol is low and LH is normal, consider that the testes are not getting the full signal. Some clinicians use low-dose HCG (250 IU every other day) to stimulate Leydig cells and raise intratesticular testosterone, which can also raise estradiol. But do not add HCG without a clear indication. Check estradiol on your post-PCT panel. If it is below 20 and you have symptoms, discuss options with a licensed medical professional.
The Three Markers of True Recovery
These three markers, measured together, tell you whether your HPTA has truly recovered or is still struggling:
LH (Luteinizing Hormone)
FSH (Follicle-Stimulating Hormone)
Total Testosterone
The Testosterone/LH Ratio
Three Recovery Patterns and What They Mean
Post-PCT blood work almost always falls into one of three patterns, and figuring out which one you're in is what decides your next move.
Full Recovery
When your LH sits above 4.0, FSH above 4.0, and total testosterone clears 500 ng/dL or lands within 80% of your pre-cycle baseline, you're in a good spot. No further intervention is needed at that point. Just keep monitoring quarterly for 1 year to confirm everything stays stable.
Partial Recovery — Leydig Cell Issue
LH is normal (> 4.0) but total T is low (< 350). This suggests Leydig cells are not responding adequately. Options: extended recovery time (up to 6 months), HCG stimulation test, or accepting TRT. Do not run another PCT: the pituitary is working, the problem is at the testicular level.
When LH is normal but total T is low, the problem is testicular. This is called secondary hypogonadism with primary testicular failure, or mixed hypogonadism. It often occurs after long-term AAS use, especially with 19-nor compounds like trenbolone, which can cause lasting Leydig cell damage. An HCG stimulation test, administered and interpreted by a licensed medical professional, can differentiate between Leydig cell desensitization and permanent damage: total T is measured, HCG is given, and total T is remeasured 72 hours later. A doubling of testosterone or an increase of at least 150 ng/dL indicates the testes can still respond. If the response is blunted, recovery may take up to 6 months, and a licensed medical professional may use low-dose HCG over several weeks to help re-sensitize Leydig cells. Do not run another PCT; the pituitary is working. If after 6 months total T remains below 300, TRT is a reasonable option.
Incomplete Recovery — Pituitary Suppression
LH is low (< 2.0), FSH is low, total T is low. The pituitary has not resumed signaling. Options: if within 8 weeks of PCT, continue monitoring. If past 12 weeks, consider a second PCT round with clomiphene or enclomiphene. If no response after two PCT rounds, TRT is the likely permanent outcome.
A second PCT round is not a repeat of the first. If LH and FSH are still low at week 12, the pituitary is not responding. This is a case for a licensed medical professional: a SERM like clomiphene or enclomiphene is the usual choice (enclomiphene tends to have fewer side effects and a cleaner profile), but getting the dose, duration, and monitoring right needs someone managing it directly. HCG is generally avoided in this situation since it suppresses LH further by mimicking testosterone feedback. Monitor LH and FSH after 2 weeks of the second round. If LH rises, that's a good sign; if there is no response after 4 weeks, the chance of recovery drops significantly. After two failed PCT rounds, the likelihood of spontaneous recovery is low. At that point, TRT is the pragmatic choice. But before committing, check prolactin and thyroid function, as hyperprolactinemia or hypothyroidism can also suppress LH. Rule out these correctable causes first.
Retesting Schedule and Decision Points
A single post-PCT blood draw isn't enough. Recovery is a process, not an event, and the trend matters more than any single value. Here's the recommended retesting schedule.
- At 4 weeks post-PCT, you want LH, FSH, and total testosterone on the panel. This is a progress check, not a recovery assessment, so don't panic if values are still low. LH often just begins rising at week 4.
- At the 8 weeks post-PCT mark, you do a full assessment. This is the earliest point for a reliable recovery determination. If LH > 4.0 and FSH > 4.0, recovery is active.
- At the 12 weeks post-PCT mark, you're looking for confirmation. Total testosterone should be at or near baseline, and if it's not, this is the point for clinical decision-making.
- 16-24 weeks post-PCT: Semen analysis if fertility is a goal. Blood work alone cannot confirm fertility.
The "In Range" Trap
PCT Failure: When to Accept TRT as an Outcome
Not every HPTA recovers. After prolonged or heavy AAS use, particularly with compounds like trenbolone, nandrolone, or high-dose testosterone, some users experience permanent HPTA suppression. Accepting this is not failure, it is a rational medical decision.
Consider TRT as the outcome if:
- After 2 PCT rounds, your LH and FSH still haven't produced a significant response.
- Even if your LH and FSH come back looking perfectly normal, a total testosterone that still sits below 300 ng/dL a full 6 months after PCT tells a different story. The pituitary is sending the signal, but the testes aren't answering the call the way they should.
- If you're over 40 and your natural pre-cycle testosterone sits below 400 ng/dL, you're already starting from a deficit that most younger guys never have to think about. That number matters because it changes how your body responds to everything you put into it, and it changes what your bloodwork is going to tell you down the road.
- When you're dealing with fatigue, low libido, and depression, and your bloodwork confirms your testosterone values are sitting in the low range, that's a clear clinical picture. The symptoms line up with the numbers, which means this isn't just in your head.
TRT is not a moral failure. It is a medical intervention for hypogonadism, whether that hypogonadism is iatrogenic (AAS-induced) or primary. The key is making an informed decision based on blood work, not on ego.